Cigna, Express Scripts announce Patient Assurance Program to cap insulin costs

Addressing the need for greater affordability and access to insulin, Cigna (CI) and Express Scripts (ESRX) announced the launch of the Patient Assurance Program, which will ensure eligible people with diabetes in participating plans pay no more than $25 for a 30-day supply of insulin. The Patient Assurance Program will be available to members in participating non-government funded pharmacy plans managed by Express Scripts, including Cigna and many other health plans, with out-of-pocket costs for insulin greater than $25. Out of pocket costs for insulin include deductibles, copays or coinsurance. In most cases, people who use insulin will see lower out-of-pocket costs without any increased cost to the plan. Cigna and Express Scripts clients will activate this new program for participating plans by moving covered insulin products to a lower copayment. For users of insulin plans managed by Cigna and Express Scripts, the average out-of-pocket cost for insulin was $41.50 for a 30-day supply in 2018. Through the Patient Assurance Program, individuals who are eligible for the program will save approximately 40%, as well as gain peace of mind in knowing they will have access to improved affordability. Individuals with plan designs that involve coinsurance and/or a high deductible, will benefit the most from this new program.

https://thefly.com/landingPageNews.php?id=2887887